UNSPSC 51111845: Dromostanolone or drostanolone

This classification denotes a therapeutic androgen with the molecular formula C20H32O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7DR7H00HDT, chemically known as (2R,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one but generally known as dromostanolone, which bears US NIH Compound Identifier 6011. SMILES:CC1CC2(C(CCC3C2CCC4(C3CCC4O)C)CC1=O)C. Dromostanolone or drostanolone bears US NLM identifiers UMLS ID C0058753 and NCI Concept Code C1076.

I cannot write a meaningful summary for this UNSPSC code based on the source provided. UNSPSC 51111845 Dromostanolone or drostanolone is a pharmaceutical Commodity code for a specific anabolic steroid, and the source contains no information about state and local procurement activity, issuing bodies, recent solicitations, geographic distribution, or use cases. State and local governments do not routinely solicit this controlled substance through public procurement channels, and the source provides no evidence of any recent opportunities under this code. Without concrete procurement intelligence from the recent-opportunities block, I cannot characterize the issuing-body mix, geographic spread, or representative work being solicited—the core decision-making signals your business development team needs.